KRYS
Krystal Biotech
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: KRYS
- PEG Ratio
KRYS currently shows a PEG ratio reading of 0.67 as of Sep 23, 2026. This result reflects a P/E ratio of 41.32 measured against EPS growth of 61.8%. When compared to the trailing 4-quarter average of 0.38, KRYS's PEG ratio reflects a 77% increase.
KRYS PEG ratio history
A three years lookback reveals an average PEG ratio of 0.63 for Krystal Biotech. Compared to historical data, KRYS's 0.67 PEG ratio represents an increase of 6%. KRYS hit its maximum PEG ratio of 2.89 during the Dec 2023 quarter over the last three years. The Dec 2024 quarter marked the lowest reading at 0.07, indicating the most favorable growth-adjusted valuation.
Krystal Biotech PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.27 | 34.82 | 126.9% |
| 2024 | 0.07 | 50.21 | 680% |
| 2023 | 2.89 | 310.15 | 107.3% |
| 2022 | N/A | N/A | -75.4% |
| 2021 | N/A | N/A | -83% |
| 2020 | N/A | N/A | -42.5% |
| 2019 | N/A | N/A | -23.7% |
| 2018 | N/A | N/A | 34.5% |
| 2017 | N/A | N/A | -13% |
| 2016 | N/A | N/A | N/A |
Krystal Biotech PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 0.73 | 44.94 | 61.8% |
| Mar 2026 | 0.42 | 33.33 | 79.4% |
| Dec 2025 | 0.27 | 34.82 | 126.9% |
| Sep 2025 | 0.09 | 25.58 | 275% |
| Jun 2025 | 0.76 | 26.9 | 35.5% |
| Mar 2025 | 0.35 | 41.74 | 118.2% |
| Dec 2024 | 0.07 | 50.21 | 680% |
| Sep 2024 | 0.42 | 98.93 | 233.3% |
| Jun 2024 | 0.29 | 48.71 | 169.4% |
| Mar 2024 | 0.65 | 89.86 | 137.5% |
| Dec 2023 | 2.89 | 310.15 | 107.3% |
| Sep 2023 | N/A | N/A | 73.5% |
| Jun 2023 | N/A | N/A | -14.6% |
| Mar 2023 | N/A | N/A | -20.5% |
| Dec 2022 | N/A | N/A | -75.4% |
KRYS average PEG ratio chart
When comparing to historical data, KRYS's PEG ratio sits above the 3 and 5-year averages.
PEG comparison
Krystal Biotech's PEG of 0.67 is higher than the Healthcare sector and the industry average. Looking at the Healthcare sector average of 0.53, Krystal Biotech's PEG is 26% higher.
KRYS EPS growth
KRYS Price vs fair value
KRYS PEG vs peers
KRYS reports a PEG ratio higher than that of peer stocks OMER and ORMP.
Frequently asked questions
What is Krystal Biotech's PEG ratio?
According to Sep 23, 2026 figures, KRYS's PEG ratio stands at 0.67.
What is the 3-year average PEG ratio for Krystal Biotech (KRYS)?
Historical data over a 3-year period puts KRYS's average PEG ratio at 0.63.
What is the 5-year average PEG ratio for Krystal Biotech (KRYS)?
Historical data over a 5-year period puts KRYS's average PEG ratio at 0.63.
What is the highest PEG ratio for KRYS?
KRYS's PEG ratio topped out at 2.89 during the Dec 2023 quarter - the highest in three years.
How does the current PEG ratio for KRYS compare to its historical average?
At present, KRYS's PEG ratio is 6% higher than its 3-year historical average.
How is KRYS's PEG ratio calculated (Krystal Biotech PEG ratio formula)?
The PEG ratio derives from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Sep 23, 2026, Krystal Biotech has a PE ratio of 41.32. Earnings grew at 61.8% over the TTM period ending Jun 2026. Applying the formula, this gives a PEG ratio of 0.67. PEG RATIO(0.67) = PE RATIO(41.32) / EPS GROWTH(61.8%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.